8-KItem 7.01 · Reg FD DisclosureItem 8.01 · Other EventsItem 9.01 · Financial Statements
Moderna ($MRNA) said on Feb 10, 2026 it received a Refusal-to-File letter from the FDA for its…
Filed with the SEC on · Summarized by InvestorsBot
Moderna ($MRNA) said on Feb 10, 2026 it received a Refusal-to-File letter from the FDA for its investigational seasonal influenza vaccine mRNA-1010. Press release furnished as Exhibit 99.1 to Form 8-K. ⚠️ #Moderna #FDA #mRNA
8-K Item 7.01 notes the disclosure and Exhibit 99.1 are furnished (not "filed") under the Exchange Act and are not subject to Section 18 liability or incorporated by reference unless expressly stated. 📝 $MRNA #Moderna #SEC